The PTX-increased expression of NOD2 suggests its anti-tumor activity and capacity to significantly increase the chemosensitivity of MDA-MB-231 cells to PTX, being able to increase the pyroptosis rate of tumor cells after treatment. This evidence concerns the gene NOD2 and neoplasm.